| Revenue | SEK 115K | — |
| EBITDA | SEK 17K | — |
| Net profit | SEK 3M | +3272% |
| Total assets | SEK 8,3M | -6% |
| Equity | SEK 8,1M | -8% |
| Employees | 0 | — |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | 14 925 | 0 | 0 | 0 | 93 299 | 0 | 115 |
| Staff expenses | — | — | — | — | — | — | — | — |
| EBITDA | 2 556 | 14 729 | −3 | −490 | −925 | 21 427 | — | 17 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −3 116 | −0 | −0 |
| EBIT | 2 556 | 14 729 | −3 | −490 | −925 | 18 311 | 0 | 17 |
| Net financials | — | — | 9 525 | 19 800 | — | −699 | 8 | 2 996 |
| Profit before tax | 2 556 | 14 729 | 9 522 | 19 310 | −925 | 17 612 | −95 | 3 013 |
| Tax | −0 | −0 | −0 | −0 | −0 | −3 925 | −0 | −0 |
| Net profit | 2 556 | 14 729 | 9 522 | 19 310 | −925 | 13 687 | −95 | 3 013 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 2 606 | 14 872 | 13 433 | 22 807 | 13 214 | 14 895 | 8 799 | 8 256 |
| Equity | 2 606 | 14 835 | 13 358 | 22 667 | 13 142 | 14 891 | 8 795 | 8 109 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 37 | 75 | 140 | 72 | 4 | 4 | 147 |
| Total debt | — | 37 | 75 | 140 | 72 | 4 | 4 | 147 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SJ Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
| Person | Role here | Other companies |
|---|---|---|
| Sten Johan Pharmanson | Chief Auditor | 0 companies |
| Pooya Madjidi Bergström | Deputy Board Member | 0 companies |
| Homan Panahi | Board of Directors | 0 companies |